WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. Financials - Benzinga

WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc.

WINTOTCEM

Trade with Public

Trade with Public

$0.1100

At close: Aug 29, 5:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare

WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. Financials

WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (WINT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Windtree Therapeutics Q3 EPS $(1.08) Up From $(211.38) YoY

Windtree Therapeutics (OTC:WINT) reported quarterly losses of $(1.08) per share. This is a 99.49 percent increase over losses of $(211.38) per share from the same period last year.

Benzinga Newsdesk

Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings

Avi Kapoor

PRO
Windtree Therapeutics Q4 EPS $(4.63) Beats $(28.82) Estimate

Windtree Therapeutics (NASDAQ:WINT) reported quarterly losses of $(4.63) per share which beat the analyst consensus estimate of $(28.82) by 83.93 percent. This is a 100.42 percent decrease over earnings of $1.10 thousand

Benzinga Newsdesk

PRO
Windtree Therapeutics FY 2024 GAAP EPS $(104.35)

Benzinga Newsdesk

US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking 'More Balanced' And Gone From 'Above-Trend To On-Trend,' Says Expert

U.S. stock futures were trading lower on Wednesday, after advancing for three consecutive sessions. Futures of major benchmark indices were lower in premarket trading.

Rishabh Mishra

Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase

Avi Kapoor